Logo image of CRAI

CRA INTERNATIONAL INC (CRAI) Stock Fundamental Analysis

NASDAQ:CRAI - Nasdaq - US12618T1051 - Common Stock - Currency: USD

200.99  -9.98 (-4.73%)

After market: 200.99 0 (0%)

Fundamental Rating

4

CRAI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. Both the profitability and the financial health of CRAI get a neutral evaluation. Nothing too spectacular is happening here. CRAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRAI had positive earnings in the past year.
CRAI had a positive operating cash flow in the past year.
CRAI had positive earnings in 4 of the past 5 years.
Of the past 5 years CRAI 4 years had a positive operating cash flow.
CRAI Yearly Net Income VS EBIT VS OCF VS FCFCRAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1.2 Ratios

CRAI has a Return On Assets of 7.38%. This is in the better half of the industry: CRAI outperforms 73.42% of its industry peers.
CRAI's Return On Equity of 21.02% is fine compared to the rest of the industry. CRAI outperforms 72.15% of its industry peers.
CRAI has a Return On Invested Capital of 13.12%. This is in the better half of the industry: CRAI outperforms 75.95% of its industry peers.
CRAI had an Average Return On Invested Capital over the past 3 years of 12.81%. This is in line with the industry average of 13.65%.
The 3 year average ROIC (12.81%) for CRAI is below the current ROIC(13.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.38%
ROE 21.02%
ROIC 13.12%
ROA(3y)7.43%
ROA(5y)6.11%
ROE(3y)19.61%
ROE(5y)16.2%
ROIC(3y)12.81%
ROIC(5y)10.31%
CRAI Yearly ROA, ROE, ROICCRAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

CRAI's Profit Margin of 6.39% is fine compared to the rest of the industry. CRAI outperforms 69.62% of its industry peers.
CRAI's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.88%, CRAI is doing good in the industry, outperforming 74.68% of the companies in the same industry.
CRAI's Operating Margin has improved in the last couple of years.
CRAI's Gross Margin of 29.81% is on the low side compared to the rest of the industry. CRAI is outperformed by 63.29% of its industry peers.
CRAI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.88%
PM (TTM) 6.39%
GM 29.81%
OM growth 3Y10.45%
OM growth 5Y5.91%
PM growth 3Y8.59%
PM growth 5Y2.76%
GM growth 3Y2.92%
GM growth 5Y-0.82%
CRAI Yearly Profit, Operating, Gross MarginsCRAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRAI is still creating some value.
There is no outstanding debt for CRAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRAI Yearly Shares OutstandingCRAI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CRAI Yearly Total Debt VS Total AssetsCRAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

CRAI has an Altman-Z score of 4.35. This indicates that CRAI is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.35, CRAI is doing good in the industry, outperforming 79.75% of the companies in the same industry.
CRAI has a debt to FCF ratio of 2.50. This is a good value and a sign of high solvency as CRAI would need 2.50 years to pay back of all of its debts.
The Debt to FCF ratio of CRAI (2.50) is better than 67.09% of its industry peers.
CRAI has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.29, CRAI is in line with its industry, outperforming 53.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.5
Altman-Z 4.35
ROIC/WACC1.45
WACC9.06%
CRAI Yearly LT Debt VS Equity VS FCFCRAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.06 indicates that CRAI should not have too much problems paying its short term obligations.
The Current ratio of CRAI (1.06) is worse than 70.89% of its industry peers.
CRAI has a Quick Ratio of 1.06. This is a normal value and indicates that CRAI is financially healthy and should not expect problems in meeting its short term obligations.
CRAI's Quick ratio of 1.06 is on the low side compared to the rest of the industry. CRAI is outperformed by 70.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
CRAI Yearly Current Assets VS Current LiabilitesCRAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.25% over the past year.
Measured over the past years, CRAI shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.24% on average per year.
EPS 1Y (TTM)38.25%
EPS 3Y11.47%
EPS 5Y20.24%
EPS Q2Q%24.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.17%

3.2 Future

CRAI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.72% yearly.
The Revenue is expected to grow by 1.61% on average over the next years.
EPS Next Y3.3%
EPS Next 2Y4.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.4%
Revenue Next 2Y1.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRAI Yearly Revenue VS EstimatesCRAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
CRAI Yearly EPS VS EstimatesCRAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.48, CRAI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CRAI is on the same level as its industry peers.
CRAI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.64 indicates a quite expensive valuation of CRAI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRAI is on the same level as its industry peers.
CRAI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.48
Fwd PE 25.64
CRAI Price Earnings VS Forward Price EarningsCRAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRAI.
63.29% of the companies in the same industry are cheaper than CRAI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 56.72
EV/EBITDA 18.08
CRAI Per share dataCRAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRAI does not grow enough to justify the current Price/Earnings ratio.
CRAI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.03
PEG (5Y)1.31
EPS Next 2Y4.72%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

CRAI has a Yearly Dividend Yield of 1.03%. Purely for dividend investing, there may be better candidates out there.
CRAI's Dividend Yield is a higher than the industry average which is at 1.93.
With a Dividend Yield of 1.03, CRAI pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

CRAI has been paying a dividend for over 5 years, so it has already some track record.
As CRAI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years8
Div Non Decr Years8
CRAI Yearly Dividends per shareCRAI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

CRAI pays out 27.65% of its income as dividend. This is a sustainable payout ratio.
DP27.65%
EPS Next 2Y4.72%
EPS Next 3YN/A
CRAI Yearly Income VS Free CF VS DividendCRAI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CRAI Dividend Payout.CRAI Dividend Payout, showing the Payout Ratio.CRAI Dividend Payout.PayoutRetained Earnings

CRA INTERNATIONAL INC

NASDAQ:CRAI (2/21/2025, 8:10:48 PM)

After market: 200.99 0 (0%)

200.99

-9.98 (-4.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners89.05%
Inst Owner Change4.27%
Ins Owners4.12%
Ins Owner Change-2.04%
Market Cap1.36B
Analysts82.5
Price Target215.22 (7.08%)
Short Float %0.78%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend1.54
Dividend Growth(5Y)N/A
DP27.65%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.72%
Min EPS beat(2)9.83%
Max EPS beat(2)19.61%
EPS beat(4)4
Avg EPS beat(4)27.88%
Min EPS beat(4)9.83%
Max EPS beat(4)44.84%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)9
Avg EPS beat(12)14.31%
EPS beat(16)13
Avg EPS beat(16)21.78%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.88%
Max Revenue beat(2)-0.1%
Revenue beat(4)2
Avg Revenue beat(4)2.03%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)5.86%
Revenue beat(8)3
Avg Revenue beat(8)-0.83%
Revenue beat(12)4
Avg Revenue beat(12)-0.54%
Revenue beat(16)7
Avg Revenue beat(16)0.76%
PT rev (1m)0%
PT rev (3m)9.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)0%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 26.48
Fwd PE 25.64
P/S 2.03
P/FCF 56.72
P/OCF 44.81
P/B 6.66
P/tB 13.32
EV/EBITDA 18.08
EPS(TTM)7.59
EY3.78%
EPS(NY)7.84
Fwd EY3.9%
FCF(TTM)3.54
FCFY1.76%
OCF(TTM)4.49
OCFY2.23%
SpS99.2
BVpS30.16
TBVpS15.09
PEG (NY)8.03
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 7.38%
ROE 21.02%
ROCE 21.15%
ROIC 13.12%
ROICexc 14.04%
ROICexgc 19.84%
OM 9.88%
PM (TTM) 6.39%
GM 29.81%
FCFM 3.57%
ROA(3y)7.43%
ROA(5y)6.11%
ROE(3y)19.61%
ROE(5y)16.2%
ROIC(3y)12.81%
ROIC(5y)10.31%
ROICexc(3y)14.96%
ROICexc(5y)11.91%
ROICexgc(3y)23%
ROICexgc(5y)17.95%
ROCE(3y)17.33%
ROCE(5y)13.96%
ROICexcg growth 3Y28.46%
ROICexcg growth 5Y1.97%
ROICexc growth 3Y23.95%
ROICexc growth 5Y6.89%
OM growth 3Y10.45%
OM growth 5Y5.91%
PM growth 3Y8.59%
PM growth 5Y2.76%
GM growth 3Y2.92%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.5
Debt/EBITDA 0.77
Cap/Depr 56.5%
Cap/Sales 0.95%
Interest Coverage 17.84
Cash Conversion 39.12%
Profit Quality 55.88%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 4.35
F-Score7
WACC9.06%
ROIC/WACC1.45
Cap/Depr(3y)24.24%
Cap/Depr(5y)72.63%
Cap/Sales(3y)0.5%
Cap/Sales(5y)1.71%
Profit Quality(3y)125.19%
Profit Quality(5y)116.67%
High Growth Momentum
Growth
EPS 1Y (TTM)38.25%
EPS 3Y11.47%
EPS 5Y20.24%
EPS Q2Q%24.54%
EPS Next Y3.3%
EPS Next 2Y4.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.17%
Revenue Next Year3.4%
Revenue Next 2Y1.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.73%
EBIT growth 3Y18.25%
EBIT growth 5Y14.77%
EBIT Next Year65.68%
EBIT Next 3Y18.5%
EBIT Next 5YN/A
FCF growth 1Y4.96%
FCF growth 3Y15.38%
FCF growth 5Y22.71%
OCF growth 1Y13.57%
OCF growth 3Y3.2%
OCF growth 5Y10.67%